Patients in the iNPH group also had lower p-tau (32.13 [17.85] pg/mL vs. 125.52 [63.09] pg/mL, p < 0.001, d = 2.01) and t-tau (242.66 [205.59] pg/mL vs. 768.79 [374.22] pg/mL, p < 0.001, d = 1.74) concentrations than patients in the AD group (Table 1, Figure 2). This evidence concerns the gene MAPT and Alzheimer disease.